Qin Hng Pharmaceutical: Disclosure of Reply to Inquiry Letter on Issuance of Convertible Bonds to Unsourced Objects.

Qianhong Pharmaceutical announced that it received a review inquiry letter from the Shenzhen Stock Exchange on February 12, 2026 regarding the issuance of convertible corporate bonds to unspecified parties. The company, together with the intermediary agency, will respond to the questions and revise the application documents accordingly. The response to the review inquiry letter is now disclosed. The company will submit relevant documents through the Shenzhen Stock Exchange system in the future. The issuance of convertible bonds still needs to be approved by the Shenzhen Stock Exchange and registered by the China Securities Regulatory Commission before implementation, with uncertainties existing.